Loading clinical trials...
Loading clinical trials...
The main aim of this study is to learn more about the safety profile of Elaprase in Indian children and adults with hunter syndrome. Participants will receive Elaprase once per week over a 3-hour per...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Takeda
NCT05422482 · Mucopolysaccharidosis II, Hunter Syndrome
NCT05795361 · Hunter Syndrome
NCT05494593 · Mucopolysaccharidosis (MPS), Hunter Syndrome
NCT01506141 · Hunter Syndrome
NCT02412787 · Hunter Syndrome
SAT Hospital - Govt Medical College
Thiruvananthapuram, Kerala
JK Lone Hospital
Jaipur, Rajasthan
Institute of Child Health
Kolkata
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions